Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2697 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.62 USD | -2.82% | -8.69% | -25.69% | -27.87% | 697.37 M USD | ||
| 2699 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.20 USD | -2.44% | -5.60% | -1.54% | +50.23% | 697.28 M USD | ||
| 2707 |  RGNX REGENXBIO Inc. - Common Stock | 8.14 USD | -24.07% | -24.56% | -19.00% | -39.39% | 537.35 M USD | ||
| 2709 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.59 USD | -2.36% | +2.20% | +21.74% | +8.93% | 688.26 M USD | ||
| 2712 |  ASMB Assembly Biosciences, Inc. - Common Stock | 33.83 USD | -1.60% | +4.64% | +31.12% | +14.95% | 688.80 M USD | ||
| 2757 |  HELP Cybin Inc. - Common Stock | 12.28 USD | -2.46% | +5.95% | +57.03% | +36.90% | 634.04 M USD | ||
| 2764 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 2.33 USD | -3.32% | +5.91% | +59.59% | +32.39% | 620.16 M USD | ||
| 2765 |  CRMD CorMedix Inc. - Common Stock | 8.26 USD | +0.73% | +9.40% | +3.38% | -26.90% | 643.82 M USD | ||
| 2768 |  SGMT Sagimet Biosciences Inc. - Series A Common Stock | 10.02 USD | -2.24% | -6.09% | +40.73% | +39.17% | 622.83 M USD | ||
| 2777 |  MDXG MiMedx Group, Inc - Common Stock | 4.37 USD | +0.92% | +3.31% | +3.07% | -39.89% | 636.97 M USD | ||
| 2785 |  SLN Silence Therapeutics Plc - American Depository Share | 13.22 USD | -0.38% | -4.06% | +18.78% | +169.25% | 624.60 M USD | ||
| 2789 |  VSTM Verastem, Inc. - Common Stock | 6.67 USD | -3.19% | +1.37% | +8.99% | -26.54% | 604.06 M USD | ||
| 2797 |  PRME Prime Medicine, Inc. - Common Stock | 3.23 USD | -4.72% | +5.56% | +8.75% | -9.78% | 585.85 M USD | ||
| 2799 |  ARVN Arvinas, Inc. - Common Stock | 9.09 USD | -2.99% | +0.44% | +11.81% | -2.26% | 594.36 M USD | ||
| 2805 |  ALT Altimmune, Inc. - Common Stock | 3.06 USD | -1.61% | +2.34% | +8.90% | -13.31% | 595.22 M USD | ||
| 2809 |  VALN Valneva SE - American Depositary Shares | 6.60 USD | -5.17% | -7.43% | +32.80% | -27.63% | 572.68 M USD | ||
| 2831 |  DRUG Bright Minds Biosciences Inc. - common stock | 75.00 USD | -3.13% | -2.15% | +5.75% | +69.76% | 572.68 M USD | ||
| 2856 |  ZURA Zura Bio Limited - Class A Ordinary shares | 5.80 USD | -0.85% | +3.39% | +9.85% | +185.71% | 555.81 M USD | ||
| 2857 |  ENTX Entera Bio Ltd. - Ordinary Shares | 3.26 USD | +0.93% | +10.88% | +12.03% | +72.49% | 564.44 M USD | ||
| 2870 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.24 USD | -4.90% | -9.50% | -12.67% | -43.11% | 521.10 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |